Evaluating Tumor Quantification in Place of Proportions in Prostate Cancer: Principles of the ProQuant Group.

Vickers AJ, Fine S, ProQuant Group

Eur. Urol. 89 (4) 298-301 [2026-04-00; online 2025-12-18]

We describe the rationale for using quantification of Gleason pattern 4 rather than the proportion of Gleason patterns for risk stratification in prostate cancer, as proposed by the ProQuant Group. We outline research that will be conducted to assess this strategy, and invite individuals interested in collaboration to join the group.

DDLS Fellow

Kimmo Kartasalo

PubMed 41419390

DOI 10.1016/j.eururo.2025.11.013

Crossref 10.1016/j.eururo.2025.11.013

pii: S0302-2838(25)04835-3


Publications 9.5.2